Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?

Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Pul, Refik, Osmanovic, Alma, Schmalstieg, Holger, Pielen, Amelie, Pars, Kaweh, Schwenkenbecher, Philipp, Sühs, Kurt Wolfram, Yildiz, Özlem, Frank, Benedikt, Stangel, Martin, Skripuletz, Thomas
Format: Artigo
Language:Inglês
Published: MDPI 2016
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5187906/
https://ncbi.nlm.nih.gov/pubmed/27983657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17122106
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items